The Indian market has massive potential and can be the source of many future innovations, British FMCG major RB Plc’s global CEO Laxman Narasimhan said on Wednesday.
The company expects that the innovations will unleash the potential of the consumption class, he said while addressing a session at the CII National FMCG Summit.
“I am deeply optimistic that a lot of the future innovation will come from India. I have my eyes out for that,” Narasimhan said in his virtual address, adding that “the potential of India is massive”.
RB sells a range of hygiene products in India, including Dettol, Lizol and Harpic, while in the health segment it has some popular brands like Disprin and Strepsils.
Narasimhan also said the post-pandemic world will see a more permanent reset of consumer behaviour, and the shift that has happened towards digital is going to stay.
The pandemic phase has also led to “reimagining of the consumer’s experiences” and “conscious consumption”, he said. “So, I think we are going to see three things -- you are going to see digital... You are going to see a reimagining of consumer experiences done in a safe way and the third is a more conscious consumption,” Narasimhan noted.